Telescope technology used to take first undistorted images of eye area involved in glaucoma

Using methods originally developed by astronomers to view stars more clearly through Earth's atmosphere, optometry researchers at Indiana University have taken the first undistorted microscopic images of a part of the eye involved in glaucoma.

The ability to clearly view this structure -- known as the trabecular meshwork -- could help improve treatment for glaucoma. The work is reported in the Journal of Translational Vision Science and Technology.

Normally, clear fluid circulates inside the eye to supply nutrition and keep it 'inflated' to its normal shape. Alterations of the trabecular meshwork, which allows fluid to drain, elevates pressure in the eye, leading to glaucoma. The problem is the meshwork can only be seen poorly with the normal instruments in your doctor's office, due to its location where the iris inserts into the wall of the eye, as well as the near-total reflection that occurs when looking through the cornea."

Dr. Brett King, chief of advanced ocular care services, associate clinical professor at the IU School of Optometry and co-author of the study

The result of this low visibility is a lack of understanding about why age appears to cause the trabecular meshwork to function poorly. It also makes it difficult to study why certain glaucoma treatments that target the trabecular meshwork -- such as laser therapies or invasive surgical procedures -- fail while others succeed.

More effective treatments for glaucoma are needed since the number of people with the condition worldwide is expected to rise from 76 million in 2020 to over 111 million in 2040, disproportionally affecting people in Asia and Africa. In the U.S., it's estimated that over 3 million people currently have glaucoma, costing the economy over $1.5 billion annually.

To view the trabecular meshwork, IU researchers modified an existing ophthalmic laser microscope with a programmable mirror able to deform in real time to correct for the eye's imperfections. The technology, called "adaptive optics," is accurate within ten-millionths of a millimeter, which is precise enough to visualize single cells or measure blood flow inside the retina.

Designed by astronomers to correct for the same atmospheric distortions that make stars appear to twinkle, adaptive optics uses a real or artificial point of light -- whether an illuminated spot on the retina or a "guide star" in astronomy -- to rapidly compute distortion rate and then correct for it.

According to study co-author Stephen Burns, the technology is similar to "a very expensive and very versatile funhouse mirror." An IU faculty member who was not involved in this study, Donald Miller, was among the first imaging scientists to adapt the technology to imaging the eye's retina in the late 1990s. Burns has been working on the subject since the early 2000s.

The new study extends the method to a part of the eye beyond the retina. In the paper, IU researchers report that the use of adaptive optics successfully imaged the trabecular meshwork in nine study participants, including two with pigment dispersion syndrome, an eye disorder that can lead to a form of glaucoma.

"Thanks to this research, the ocular drainage area of the eye can now be seen with much-improved clarity, which will improve our understanding of how this essential drainage area is being altered or damaged with age," King said. "We're very hopeful that this technology may help improve understanding and management of glaucoma, since many members of our team are clinicians who've managed patients with this disease for years."

Source:
Journal reference:

King, B.J., et al. (2019) High-Resolution, Adaptive Optics Imaging of the Human Trabecular Meshwork In Vivo. Journal of Translational Vision Science and Technology. doi.org/10.1167/tvst.8.5.5.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-term low-dose antiviral treatment reduces eye disease risk from shingles